Medical Evidence Blog

This is discussion forum for physicians, researchers, and other healthcare professionals interested in the epistemology of medical knowledge, the limitations of the evidence, how clinical trials evidence is generated, disseminated, and incorporated into clinical practice, how the evidence should optimally be incorporated into practice, and what the value of the evidence is to science, individual patients, and society.

Showing posts with label drotrecogin-alfa. Show all posts
Showing posts with label drotrecogin-alfa. Show all posts
Wednesday, May 2, 2018

Hollow Hegemony: The Opportunity Costs of Overemphasizing Sepsis

›
Protocols are to make complex tasks simple, not simple tasks complex. - Scott K Aberegg Yet here we find ourselves some 16 years af...
Friday, May 1, 2015

Is There a Baby in That Bathwater? Status Quo Bias in Evidence Appraisal in Critical Care

›
"But we are not here concerned with hopes and fears, only the truth so far as our reason allows us to discover it."   -   Charles...
Sunday, April 6, 2014

Underperforming the Market: Why Researchers are Worse than Professional Stock Pickers and A Way Out

›
I was reading in the NYT yesterday a story about Warren Buffet and how the Oracle of Omaha has trailed the S&P 500 for four of the l...
›
Home
View web version

About Me

My photo
Scott K. Aberegg, M.D., M.P.H.
Professor of Medicine, University of Utah. Former affiliations: Outside Hospital x 7.5 years; Assistant Professor, The Ohio State University; Fellowship & MPH: Johns Hopkins Hospital & Bloomberg School of Public Health, Baltimore, MD; Residency: The University of New Mexico Health Sciences Center; MD: The Ohio State University; BA, Spanish: Miami University, Ohio. All views are my own with NO institutional endorsement.
View my complete profile
Powered by Blogger.